Ani Pharmaceuticals (ANIP) Interest Coverage Ratio Growth (1y) (2012 - 2026)
Ani Pharmaceuticals (ANIP) Interest Coverage Ratio Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn | -83.16% |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | 128.45% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -97.39% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn | -8.29% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 71.05% |
| Mar 31, 2026 | 78.42% |
| Dec 31, 2025 | 782.11% |
| Sep 30, 2025 | 289.26% |
| Jun 30, 2025 | 2.03% |
| Mar 31, 2025 | -48.92% |
| Dec 31, 2024 | -332.51% |
| Sep 30, 2024 | -153.18% |
| Jun 30, 2024 | -46.68% |
| Mar 31, 2024 | 155.67% |
| Dec 31, 2023 | 70.31% |
| Sep 30, 2023 | 630.63% |
| Jun 30, 2023 | 241.30% |
| Mar 31, 2023 | 177.94% |
| Dec 31, 2022 | 102.36% |
| Sep 30, 2022 | -17.29% |
| Jun 30, 2022 | 28.50% |
| Mar 31, 2022 | -612.83% |
| Dec 31, 2021 | -3,951.90% |
| Sep 30, 2021 | -234.68% |